This document summarizes information about serotonin and histamine, including their biosynthesis, pharmacological effects, mechanisms of action, and examples of agonists and antagonists. Serotonin is produced in the gastrointestinal tract and central nervous system. It has diverse effects, including acting as a neurotransmitter, regulating cardiovascular and gastrointestinal functions, and mediating platelet aggregation. Histamine acts through H1, H2, and H3 receptors and is involved in allergic responses. Examples are given of several drugs that act as serotonin or histamine receptor agonists or antagonists for conditions like migraine, depression, anxiety, motion sickness, and allergy treatment.
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Autac5hthistamine
1.
2.
3.
4. 5-Hydroxytryptamine (5-HT), serotonin (Page, 1976) 1. endogenous monoamine 2. central neurotransmitter 3. local (autacoid) action in various tissues Occurrence and distribution Mammalian: (1) about 90% of serotonin produced by enterochromaffin cells in intestine (Erspamer, 1930s) (2) 8% in platelet (uptake system, transporter) (3) 2% in CNS (serotonergic neurons, rostral raphe nuclei), pineal gland, hypothalamus
9. Pharmacological effects Cardiovascular system 1. Vasoconstraction (5-HT2A R.), arteriolar dilation (5-HT1 R.), peripheral adrenergic neurotransmission 2. Triphasic change in blood pressure (1) a transient decrease (reflex stimulation of chemoreceptors within the coronary arteries) (Bezold- Jarisch reflex) (2) a period of hypertension that lasts several minutes (direct constraction of blood vessels of splanchnic and renal vascular beds) (3) a prolonged period of lowered pressure (vasodilation of vessels in specific vascular beds) (ex. Skeletsl muscle) 3. heart: positive inotropic and chronotropic effect (5-HT1)
10.
11. Platelet 1. 5-HT2A produces a weak platelet aggregation, but with adhesive factor (collagen) -> 5-HT can amplify the platelet aggregation reaction and speed clot formation GI tract 1. direct stimulation of intestinal muscle 2. indirect stimulation through excitation of ganalion cells within the intestinal wall -> diarrhea and abdominal pain 3. Cisapride (5-HT4 receptor agonist) -> propulsive motor activity of stomach and small, large intestine -> treatment of motility disorder Airway bronchial smooth muscle cell constriction
12. CNS 1. stimulate afferent nerve ending, ganalion cells -> pain perception, behavior, body temperature 2. synaptic transmission -> antidepressant drugs 3. 5-HT1 receptors on adrenergic nerve terminal -> NE release 4. 5-HT3 receptor located on sensory neuron mediate a depolarizing response -> pain and itching
13. Mechanism of action ketanserin Receptor mechanism Response agonist antagonist 5-HT1A -AC Presynaptic autoreceptor which inhibt neurotransmitter release in doral raphe, hippocampus and cerebral cortex. Postsynaptic receptors at several sites including hippocampus Ergotamine Buspirone 5-HT1C PI turnover Central neuronal depolarizing -- Mianserin Ketanserine 5-HT1D - AC Vasoconstriction in some cranial vascular beds, e.g. carotid artery, pial and dural vessels. Inhibitory presynaptic autoreceptors (which reduce 5-HT release) Sumatriptan 5-HT2 PI turnover Platelet aggregation, vasoconstriction, bronchoconstriction, poatsynaptic receptors mediate central and peripheral neuronal depolarization -- Methysergide Pizotifen mianserin 5-HT3 Ion channel Central and peripheral neuronal depolarization, vomiting via sensory nerve terminals of the vagus -- ondansetron
14.
15.
16. 5-HT agonists and antagonists Ergot alkaloids (Ergotamine, dihydroergotamine, bromociptine, ergonovine, methylergonovine, methysergide ) (1) from Secale cornutum (ergot), the sclerotium of fungus ( Claviceps purpurea ) parasitizing rye (2) contain lysergic acid (3) partial 5-HT, dopaminergic and -adrenergic receptor agonists (St Anthony’s fire) (4) uterus and vascular smooth contraction (5) prevent migraine headache
21. Methysergide 1. a congener of methylergonovine and LSD 2. vasoconstrictor and inhibit 5-HT2 receptor and - adrnergic block 3. prevent migraine headache, but not effective in treatment of established migraine 4. rebound headaches may occur when the drug is withdraw 5. side effect: nausea, dizziness, insomnia, behavioral changes Cyproheptadine 1. H1, 5-HT2A receptor antagonist 2. used to relieve itiching of skin, intestinal hypermotility of carcinoid syndrom 3. side effect: antihistamine-like effect